The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Moderna, Inc(NASDAQ:MRNA) 
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a tot...
Website: http://www.modernatx.com
Founded: 2010
IPO Price: $23 (Dec 07, 2018)
Full Time Employees: 3,900 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology
Moderna Number of Twitter Followers
Moderna Number of Employees (headcount)
Moderna Days Payable Outstanding ttm (DPO)
Moderna Days Receivable Outstanding ttm (DSO)
Moderna Days Inventory Outstanding ttm (DIO)
Moderna Op Cashflow Per Share ttm
Moderna Free Cashflow Per Share ttm
Moderna Cash Per Share ttm
Moderna P/S ratio ttm
Moderna (GAAP) P/E ratio ttm
Moderna P/B ratio ttm
No extra charts and metrics for this ticker.